KCNN4 and neoplasm: Beginning 14 days postinjection, FVB/N wild‐type hosts that had received SK4 WT cells developed palpable tumours, whereas animals implanted with SK4 KO cells exhibited a significant longer tumour‐free survival time (Fig. 4C).